Tanezumab effective for hip, knee osteoarthritis
18 May 2020
byAudrey Abella
Use of the nerve growth factor (NGF) inhibitor tanezumab led to significant improvements in pain and physical function in patients with moderate-to-severe osteoarthritis (OA) of the hip and knee who have intolerance or insufficient response to standard analgesics*, a phase III study has shown.
Tanezumab effective for hip, knee osteoarthritis
18 May 2020